🔗 Visit the ClinicalTrials.gov page for NCT00093613
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Pathway inhibition: emerging molecular targets for treating glioblastoma. | Neuro Oncol | 2011 | 1.38 |
| 2 | Experimental approaches for the treatment of malignant gliomas. | Pharmacol Ther | 2010 | 1.23 |
| 3 | Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas. | Curr Cancer Drug Targets | 2010 | 1.07 |
| 4 | Unique biology of gliomas: challenges and opportunities. | Trends Neurosci | 2012 | 0.87 |